Colleagues at our Mexico office put their gaming skills to the test earlier this month at the ICON4U Super Smash Bros. Ultimate Tournament. Organised by the ICON4U Engagement and Celebrations Chapter, the event welcomed...
Designing the future
Regulatory readiness for next-generation AI-enabled software as a medical device (SaMD)
Read the whitepaperFrom here to where?
Plotting a course to bring APAC-developed drugs to the world
Read the whitepaperGlobal regulatory strategies for immunology
Success factors for hypercompetitive therapy
Read the whitepaperFrom innovation to implementation: Navigating neurologic monoclonal antibody development
Read the whitepaper
Featured solutions
Orbis
ICON’s multi-agent platform that connects human expertise, data and AI across the clinical trial lifecycle.
EngageAI
Our voice of the customer feedback platform has been enhanced using AI; transforming how we listen, respond, and act on your feedback.
Blended solutions
Bespoke, seamless solutions to meet unique sponsor challenges.
Manufacturing & Pharmacy Services
Rapid small batch formulation, manufacturing, labelling and distribution for clinical trials.
Outcome Measures
A multi-faceted approach to identifying, selecting, and implementing evidence-based measures that matter to patients.
Biotech
ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.
Cardiac Safety Solutions
End-to-end cardiac safety solutions, including ECG, event monitoring, BPM, long-term Holter monitoring, ECHO and MUGA studies.
Early Clinical and Bioanalytical Solutions
Innovative early clinical solutions that will advance your drug development strategy.
Site & Patient Solutions
Transforming recruitment through patient-centric trials and real-world, real-time data.
Market Access
Expertise in mission-critical pricing, market access, and reimbursement.
Specialty Laboratory Solutions
Supporting precision medicine programs across all phases of drug diagnostic co-development.
Webinars
Insights into first-in-human study design of oligonucleotides
Watch the webinar.
When patients lead: Breaking barriers in ultra-rare disease drug development
Watch the webinar.
ICH GCP E6(R3): Preparing for global implementation, assessing the impact, risk and requirements of the change
Watch the webinar.